Menopause

Quality statements

Statement 1 Women, trans men and non-binary people registered female at birth aged 45 or over presenting with menopause associated symptoms are diagnosed with perimenopause or menopause based on their symptoms alone, without confirmatory laboratory tests.

Statement 2 Women, trans men and non-binary people registered female at birth under 40 years presenting with menopause associated symptoms have their levels of follicle-stimulating hormone measured.

Statement 3 Women, trans men and non-binary people registered female at birth with premature ovarian insufficiency are offered hormone replacement therapy or a combined hormonal contraceptive.

Statement 4 Women, trans men and non-binary people registered female at birth having treatment for menopause-associated symptoms have a review 3 months after starting each treatment and then at least annually.

Statement 5 Women, trans men and non-binary people registered female at birth who are likely to go through menopause as a result of medical or surgical treatment are given information about menopause and fertility before they have their treatment.